Bioventus Operating Income

Bioventus (BVS) currently reports a operating income of $63M as of March 2026. That compares with $23M in the prior-year period — up 177.1% year over year. Use the charts on this page to explore Bioventus's operating income history and peer comparisons.

Bioventus's operating income increased from $23M to $63M — a 177.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bioventus reported $63M in operating income as of March 2026. That compares with $23M in the prior-year period — up 177.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $63M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bioventus, and consider following BVS for alerts when major investors trade the stock.

Bioventus is classified in the Healthcare sector. On operating income, it currently shows $63M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BVS with unrelated industries.